Merck expecting up to $6B in sales of COVID-19 pill this year

Merck said on Thursday that it had sold $952 million of its antiviral COVID-19 pill and was on track to sell another $5 billion to $6 billion for the year. The company has already delivered its product to 25 countries and has agreements with…